Concepedia

Effects of single and repeated administration of 1,2,3,4-tetrahydroisoquinoline analogs on the binding of [ 11 C]raclopride to dopamine D 2 receptors in the mouse brain

Kiichi Ishiwata, Yasuhiro Koyanagi, Teppei Saitoh, Kyoji Taguchi, Jun Toda, T. SANO, Michio Senda

Journal of Neural Transmission · 2001 · 10 citations · 18 references

DOI

Concepts

References

18

Endogenous dopamine lowers the dopamine D<sub>2</sub> receptor density as measured by [<sup>3</sup>H]raclopride: Implications for positron emission tomography of the human brain

Philip Seeman, H C Guan, Hyman B. Niznik · Synapse · 1989 · 295 citations

, , +16

Striatal binding of the PET ligand <sup>11</sup>C‐raclopride is altered by drugs that modify synaptic dopamine levels

Stephen L. Dewey, Gwenn S. Smith, Jean Logan et al. · Synapse · 1993 · 284 citations

, , +14

An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions

Toshiharu Nagatsu, Mitsuo Yoshida · Neuroscience Letters · 1988 · 198 citations

, , +17

Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in Parkinsonian and normal human brains

Toshimitsu Niwa, Naohito Takeda, Norio Kaneda et al. · Biochemical and Biophysical Research Communications · 1987 · 185 citations

, , +8

&lt;b&gt;TETRAHYDROISOQUINOLINE AND 1-METHYL-TETRAHYDROISOQUINOLINE ARE PRESENT IN THE HUMAN BRAIN: RELATION TO PARKINSON’S &lt;/b&gt;&lt;b&gt;DISEASE &lt;/b&gt;

Shigeru Ohta, Michihiro Kohno, Yukiko Makino et al. · Biomedical Research · 1987 · 142 citations · Full text

, , +11